India Blood Collection Devices Market Overview, 2031

Key Insights

• According to the research report, "India Blood Collection Devices Market Outlook, 2031," published by Bonafide Research, the India Blood Collection Devices Market is expected to reach a market size of more than 1.06 Billion by 2031.
• India’s blood collection devices market is rapidly evolving due to the aggressive expansion of corporate hospital networks and major diagnostic chain consolidations into semi-urban and rural areas. The domestic blood banking infrastructure continues to expand, pushing the national demand for specialized PVC blood bags and single-use blood bags to over USD 53 million annually.
• Major technological breakthroughs in the region revolve around domestic, low-cost safety blood collection systems and specialized micro-sampling devices. Local manufacturers have developed cost-competitive, safety-engineered vacuum tubes and single-step capillary tubes engineered specifically for high-throughput, ambient-temperature diagnostic testing in decentralized field settings. Furthermore, the market has seen a rapid manufacturing shift toward shatter-resistant PET (polyethylene terephthalate) and medical-grade polypropylene blood collection tubes, displacing fragile glass containers to withstand harsh transit conditions across regional logistics networks.
• The landscape is heavily defined by government initiatives aimed at reducing import dependence through Make in India mandates and the Production Linked Incentive (PLI) scheme for medical devices. Under these policies, domestic manufacturing hubs in states like Gujarat, Haryana, and Tamil Nadu have scaled production, reducing reliance on western imports for standard blood collection needles and blood bags. Additionally, the Government of India's National Health Policy initiatives such as free diagnostic service schemes at Primary Health Centres (PHCs) utilize millions of blood collection consumables daily, making public healthcare procurement one of the largest single volume buyers in the country.

Market Outlook

• The demand for blood collection devices will increasingly shift toward home-based phlebotomy services and automated specimen management workflows. Fueled by the rise of wellness diagnostics and home lab tests across Tier-2 and Tier-3 cities, diagnostic centers are heavily investing in self-contained sample collection kits, pre-barcoded vacuum tubes, and safety lancets to streamline logistics, maintain sample integrity during transport, and minimize pre-analytical laboratory errors.
• Industry standardization and local manufacturing expansion will be driven by health regulatory frameworks overseen by the Central Drugs Standard Control Organization (CDSCO) alongside major industry bodies like the Association of Diagnostics Manufacturers of India (ADMI) and the Medical Technology Association of India (MTaI), with leading domestic and international players such as Becton Dickinson India, Terumo India, Hindustan Syringes & Medical Devices (HMD), Advin Health Care, Greiner Bio-One, and CML Biotech shaping the competitive dynamic across the country.

Market Dynamics

Driver: Expansion of diagnostic infrastructure and preventive health screenings
India's healthcare landscape is experiencing rapid modernization, driven by the expansion of corporate diagnostic chains, government-backed wellness schemes (such as Ayushman Bharat), and rising consumer awareness around preventive health checks. This widespread push for early disease detection, routine pathology tests, and diabetes monitoring creates a massive, continuous volume demand for essential blood collection consumables like vacuum tubes, needles, and lancets.
Challenge: Price sensitivity and dominance of low-cost alternatives
The Indian medical devices market is intensely cost-driven. A large segment of standalone laboratories and smaller municipal hospitals prioritize low procurement costs over advanced safety features. This heavily squeezes profit margins for premium, safety-engineered devices and makes it difficult for international manufacturers to compete against cheap, domestic or unorganized-sector alternatives.
Trend: Shift toward local manufacturing (Make in India) and quality standardization
Backed by government import substitution initiatives and stricter regulatory enforcement, there is a strategic shift toward domestic manufacturing of medical plastics and blood collection tubes. Local players are upgrading cleanroom infrastructure and aligning with global quality certifications to reduce reliance on imports and win institutional government tenders.

Regulations and Policies

• CDSCO Medical Device Rules (MDR, 2017): The overarching legal framework governed by the Central Drugs Standard Control Organization (CDSCO) that regulates the import, manufacturing, clinical investigation, sale, and distribution of all medical devices in India.
• Risk-Based Classification: Blood collection tubes and general diagnostic accessories are regulated under specific risk categories (e.g., standard blood collection tubes generally fall under lower risk tiers like Class A, while specialized blood bags or devices with active components can fall under higher classes like Class C).
• Mandatory Registration and Import Licensing: Importers and foreign manufacturers must obtain an import license (via the online CDSCO SUGAM portal) by submitting a Device Master File (DMF), ISO 13485 quality certifications, and free-sale certificates from their home country.
• Bureau of Indian Standards (BIS) Compliance: Certain medical disposables and plastic items must adhere to specific Indian Standards specifications to ensure material safety, biocompatibility, and structural integrity..

Segment Analysis

India Blood Collection Devices Market By Product Type
• Blood collection tubes in India are increasingly differentiated by additive chemistry, vacuum consistency, specimen stability, tube material, labeling, and compatibility with automated laboratory systems. The country's IVD classification specifically identifies blood collection tubes as specimen-receptacle devices intended for primary containment of predetermined blood volumes, including tubes containing EDTA, heparin, clot activators, inhibitors, or other coatings. This creates opportunities for application-specific tubes rather than generic collection containers.
• Needles and syringes remain essential products across India's hospital, diagnostic, emergency, and outpatient environments, with product differentiation increasingly centered on sterility, sharps safety, ergonomic handling, puncture precision, and compatibility with evacuated collection tubes. CDSCO's classification specifically identifies disposable blood-collecting needles intended for use with evacuated blood collection tubes, reinforcing their role as purpose-specific medical devices.
• Blood bags occupy a highly regulated and specialized position because they directly support donor blood collection and the preparation, storage, and transfusion of blood components. India's Medical Devices Rules specifically include blood and blood-component collection bags within the medical-device framework, making regulatory compliance an important consideration for manufacturers and suppliers. Product differentiation centers on sterile closed-system construction, anticoagulant compatibility, tubing configuration, component separation, labeling, traceability, and compatibility with blood-bank processing equipment.
• Blood collection systems and monitors are particularly relevant to India's blood centres, transfusion departments, and apheresis facilities, where collection can involve controlled blood flow, anticoagulant administration, component separation, and monitoring of procedure conditions. Unlike basic venipuncture devices, these systems need to function as part of a broader blood-processing workflow and therefore compete on reliability, monitoring capability, safety alarms, equipment compatibility, maintenance support, and operator usability.
• Lancets are strongly associated with capillary blood sampling, glucose monitoring, point-of-care diagnostics, pediatric testing, and decentralized healthcare. India's diverse healthcare geography makes simple blood-sampling devices particularly valuable in settings where conventional venous collection and laboratory infrastructure may be less accessible. Product differentiation focuses on controlled penetration depth, low-pain sampling, single-use construction, reliable specimen acquisition, and safe sharps disposal.
• Others category includes micro-collection devices, capillary collection products, blood-gas accessories, specimen-transfer components, adapters, collection holders, and specialized sampling products. India's large and heterogeneous healthcare system creates demand for devices that can accommodate pediatric patients, outpatient diagnostics, emergency testing, point-of-care applications, and specialized laboratory procedures.

India Blood Collection Devices Market By End-User
• Hospitals and ambulatory surgical centres use blood collection devices across emergency departments, inpatient wards, surgery, intensive care, oncology, outpatient procedures, and routine diagnostics. India's hospital landscape ranges from sophisticated tertiary-care institutions to smaller regional facilities, creating demand for both advanced automated-compatible products and robust basic collection devices. Hospitals increasingly value safety-engineered needles, standardized tubes, closed collection systems, and products that integrate with laboratory information systems and automated sample-processing workflows.
• Diagnostics and pathology laboratories are a particularly important environment for blood collection devices because specimen quality directly affects analytical reliability. India's expanding diagnostic-chain model encourages standardized collection procedures across multiple collection centres, making consistent tubes, additives, labeling, transport compatibility, and specimen stability important differentiators. Large laboratories increasingly use automation for sample sorting, centrifugation, aliquoting, and analysis, which favors collection products designed for automated handling.
• Blood banks and transfusion centres require specialized collection devices because the collected blood is destined for component preparation and therapeutic use rather than routine diagnostic analysis. Blood bags, donor needles, collection sets, sampling segments, component-processing accessories, and monitoring systems must support sterile collection, traceability, component integrity, storage, testing, and transfusion.
• Other end users include physician clinics, community healthcare facilities, outpatient diagnostic centres, research laboratories, occupational-health services, home-care environments, and point-of-care testing locations. Their needs generally favor compact, simple, portable, and low-volume blood-collection devices. Lancets, micro-collection tubes, capillary sampling products, and specialized syringes are particularly suitable for these settings.

India Blood Collection Devices Market By Application
• Diagnostic blood collection in India is increasingly shaped by the expansion of centralized diagnostic networks, hospital laboratories, and automated testing platforms. Collection devices need to maintain specimen integrity through venipuncture, labeling, transport, centrifugation, and analysis, with tube chemistry and additive selection matched to the intended investigation. India's CDSCO framework explicitly classifies blood collection tubes and related specimen-receptacle products as IVD devices, highlighting the importance of their intended diagnostic use.
• Therapeutic blood collection encompasses donor blood collection, component preparation, apheresis, and other procedures in which collected blood or blood components become part of patient treatment. The segment requires a higher degree of process control because collection quality directly affects the subsequent preparation, storage, and transfusion of blood components. Blood bags and specialized collection systems therefore emphasize sterile closed pathways, anticoagulant management, component integrity, traceability, and compatibility with downstream processing.

India Blood Collection Devices Market By Method
• Manual blood collection remains fundamental across India because venipuncture requires clinical judgment, patient identification, vein selection, device selection, and adaptation to individual patient circumstances. It remains particularly important in routine hospital diagnostics, outpatient clinics, emergency departments, primary-care facilities, and smaller laboratories where sophisticated collection automation may not be necessary. Product development consequently focuses on safety-engineered needles, ergonomic holders, standardized tubes, closed collection systems, and simplified specimen-transfer procedures.
• Automated blood collection is most relevant to India's specialized transfusion, apheresis, and high-throughput blood-processing environments. Automated systems can regulate collection parameters, blood flow, anticoagulant delivery, component separation, and return of non-target blood constituents, reducing the need for continuous manual intervention. Their adoption depends not only on technical capabilities but also on equipment maintenance, operator training, availability of compatible consumables, software support, and after-sales service.


Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Blood Collection Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Blood Collection Tubes
• Needles & Syringes
• Blood Bags
• Blood Collection Systems/Monitors
• Lancets
• Others

By End-User
• Hospitals and ASCs
• Diagnostics and Pathology Laboratories
• Blood Banks
• Others

By Application
• Diagnostic Application
• Therapeutic Application

By Method
• Manual
• Automated